[go: up one dir, main page]

UA66872C2 - Сполука, яка є памоатом оланзапіну або його сольватом, та спосіб лікування психотичних розладів - Google Patents

Сполука, яка є памоатом оланзапіну або його сольватом, та спосіб лікування психотичних розладів

Info

Publication number
UA66872C2
UA66872C2 UA2001032118A UA2001032118A UA66872C2 UA 66872 C2 UA66872 C2 UA 66872C2 UA 2001032118 A UA2001032118 A UA 2001032118A UA 2001032118 A UA2001032118 A UA 2001032118A UA 66872 C2 UA66872 C2 UA 66872C2
Authority
UA
Ukraine
Prior art keywords
olanzapine
solvates
pharmaceutical compositions
pamoate
psychotic disorders
Prior art date
Application number
UA2001032118A
Other languages
English (en)
Russian (ru)
Inventor
Чарльз Артур Баннелл
Томас Гаррі Фергюсон
Беррі Арнольд ХЕНДРІКСЕН
Мануель Вісенте Санчез-Фелікс
Девід Едуард Таппер
Original Assignee
Елі Ліллі Енд Компані
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/163,769 external-priority patent/US6169084B1/en
Application filed by Елі Ліллі Енд Компані filed Critical Елі Ліллі Енд Компані
Publication of UA66872C2 publication Critical patent/UA66872C2/uk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Anesthesiology (AREA)
  • Psychiatry (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Винахід стосується нових солей або сольватів оланзапіну памоату, що застосовують при лікуванні психозів, гострих маніакальних синдромів або станів легкої тривоги.
UA2001032118A 1998-09-30 1999-03-24 Сполука, яка є памоатом оланзапіну або його сольватом, та спосіб лікування психотичних розладів UA66872C2 (uk)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US16376898A 1998-09-30 1998-09-30
US09/163,769 US6169084B1 (en) 1997-09-30 1998-09-30 2-methyl-thieno-benzodiazepine formulation
PCT/US1999/006417 WO2000018408A1 (en) 1998-09-30 1999-03-24 2-methyl-thieno-benzodiazepine formulation

Publications (1)

Publication Number Publication Date
UA66872C2 true UA66872C2 (uk) 2004-06-15

Family

ID=26859927

Family Applications (1)

Application Number Title Priority Date Filing Date
UA2001032118A UA66872C2 (uk) 1998-09-30 1999-03-24 Сполука, яка є памоатом оланзапіну або його сольватом, та спосіб лікування психотичних розладів

Country Status (28)

Country Link
EP (1) EP1119359B1 (uk)
JP (1) JP4551988B2 (uk)
CN (1) CN1146422C (uk)
AT (2) ATE359793T1 (uk)
AU (1) AU759751B2 (uk)
BR (1) BR9914156A (uk)
CA (1) CA2344873A1 (uk)
CZ (1) CZ302367B6 (uk)
DE (2) DE69917663T2 (uk)
DK (2) DK1119359T3 (uk)
EA (1) EA002580B1 (uk)
ES (2) ES2221376T3 (uk)
GE (1) GEP20094818B (uk)
HK (1) HK1041199B (uk)
HR (1) HRP20010238B1 (uk)
HU (1) HU227400B1 (uk)
ID (1) ID29574A (uk)
IL (2) IL141766A0 (uk)
MY (1) MY126476A (uk)
NO (1) NO328243B1 (uk)
NZ (1) NZ510208A (uk)
PL (1) PL196821B1 (uk)
PT (2) PT1119359E (uk)
SK (1) SK285944B6 (uk)
TR (1) TR200100885T2 (uk)
TW (1) TW577890B (uk)
UA (1) UA66872C2 (uk)
WO (1) WO2000018408A1 (uk)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ519926A (en) * 1999-12-28 2004-02-27 Cipla Ltd New polymorphic forms of olanzapine
US7022698B2 (en) 1999-12-28 2006-04-04 U & I Pharmaceuticals, Ltd. Pharmaceutical compositions containing new polymorphic forms of olanzapine and uses thereof
PL196814B1 (pl) * 2002-05-17 2008-02-29 Inst Farmaceutyczny Sposób wytwarzania odmiany polimorficznej I olanzapiny i jej solwaty
HU226410B1 (en) 2003-04-22 2008-11-28 Egis Gyogyszergyar Nyilvanosan Novel polymorphous forms of olanzapine hydrochlorides, process for producing them, use thereof and pharmaceutical compositions containing them
US6987111B2 (en) * 2003-08-06 2006-01-17 Alkermes Controlled Therapeutics, Ii Aripiprazole, olanzapine and haloperidol pamoate salts
WO2006006185A1 (en) * 2004-07-14 2006-01-19 Shasun Chemicals And Drugs Limited Improved process for making form i of olanzapine.
ES2253091B1 (es) * 2004-07-27 2007-02-01 Inke, S.A. Solvato mixto de olanzapina, procedimiento para su obtencion y procedimiento de obtencion de la forma i de olanzapina a partir del mismo.
US20090155331A1 (en) * 2005-11-16 2009-06-18 Elan Pharma International Limited Injectable nanoparticulate olanzapine formulations
KR20130030305A (ko) * 2004-11-16 2013-03-26 엘란 파마 인터내셔널 리미티드 주사가능한 나노입자형 올란자핀 제형
US7932249B2 (en) * 2005-01-05 2011-04-26 Eli Lilly And Company Olanzapine pamoate dihydrate
CZ299218B6 (cs) * 2006-11-07 2008-05-21 Zentiva, A. S. Kompozice depotních olanzapinových injekcních systému
FR2927965B1 (fr) * 2008-02-22 2010-06-04 Valeo Materiaux De Friction Sa Procede de fabrication d'un materiau de friction et notamment d'une couronne de friction d'embrayage.
JP5486690B2 (ja) * 2009-11-16 2014-05-07 イプセン ファルマ ソシエテ パール アクシオン サンプリフィエ メラノコルチン受容体リガンドの医薬組成物
WO2011091142A2 (en) * 2010-01-20 2011-07-28 Teva Pharmaceutical Industries Ltd. Crystalline and amorphous forms of olanzapine pamoate
KR101936968B1 (ko) 2010-10-18 2019-01-09 다이닛본 스미토모 세이야꾸 가부시끼가이샤 주사용 서방형 제제
WO2014125500A1 (en) 2013-02-13 2014-08-21 Neuland Laboratories Limited A process for preparation of olanzapine pamoate
CN105044231B (zh) * 2015-06-27 2022-09-13 万特制药(海南)有限公司 一种分离测定奥氮平双羟萘酸盐一水合物有关物质的方法
CA3057438A1 (en) 2017-03-20 2018-09-27 Teva Pharmaceuticals International Gmbh Sustained release olanzapine formulaitons

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2095499A1 (en) * 1992-05-08 1993-11-09 Petrus J. M. Van Den Oetelaar Depot preparation
CA2148823C (en) * 1992-11-17 1999-03-09 Welfide Corporation Sustained release microsphere preparation containing antipsychotic drug and production process thereof
TW376319B (en) * 1993-04-28 1999-12-11 Janssen Pharmaceutica Nv Pharmaceutical composition containing risperidone pamoate and having a long acting activity for treating psychoses induced by the release of dopamine
EG23659A (en) * 1995-03-24 2007-03-26 Lilly Co Eli Process and crystal forms of methyl-thieno-benzodiazepine
US5891461A (en) * 1995-09-14 1999-04-06 Cygnus, Inc. Transdermal administration of olanzapine
HU226167B1 (hu) * 1996-09-23 2008-05-28 Lilly Co Eli Olanzapin-dihidrát D, elõállítása és az azt tartalmazó gyógyszerkészítmények
CN1239158C (zh) * 1997-09-30 2006-02-01 伊莱利利公司 2－甲基－噻吩并－苯并二氮杂䓬制剂

Also Published As

Publication number Publication date
CZ20011149A3 (cs) 2002-01-16
TW577890B (en) 2004-03-01
HU227400B1 (en) 2011-05-30
JP4551988B2 (ja) 2010-09-29
CN1320038A (zh) 2001-10-31
EA200100406A1 (ru) 2001-10-22
HK1041199B (zh) 2005-03-18
NO328243B1 (no) 2010-01-11
ES2285294T3 (es) 2007-11-16
EA002580B1 (ru) 2002-06-27
DK1119359T3 (da) 2004-08-16
NO20011583D0 (no) 2001-03-28
ATE267602T1 (de) 2004-06-15
WO2000018408A1 (en) 2000-04-06
HUP0103636A3 (en) 2003-05-28
PT1119359E (pt) 2004-08-31
JP2002525330A (ja) 2002-08-13
PL196821B1 (pl) 2008-02-29
CZ302367B6 (cs) 2011-04-13
TR200100885T2 (tr) 2001-08-21
BR9914156A (pt) 2001-06-26
PT1468689E (pt) 2007-07-09
IL141766A0 (en) 2002-03-10
CN1146422C (zh) 2004-04-21
EP1119359B1 (en) 2004-05-26
CA2344873A1 (en) 2000-04-06
SK285944B6 (sk) 2007-11-02
ES2221376T3 (es) 2004-12-16
EP1119359A4 (en) 2001-12-19
NO20011583L (no) 2001-03-28
DE69917663T2 (de) 2005-05-25
ATE359793T1 (de) 2007-05-15
MY126476A (en) 2006-10-31
DE69935873T2 (de) 2008-01-10
ID29574A (id) 2001-09-06
SK4162001A3 (en) 2002-03-05
AU759751B2 (en) 2003-05-01
DE69935873D1 (de) 2007-05-31
HUP0103636A2 (hu) 2002-01-28
AU3362799A (en) 2000-04-17
EP1119359A1 (en) 2001-08-01
IL141766A (en) 2006-12-31
NZ510208A (en) 2003-04-29
GEP20094818B (en) 2009-11-10
HRP20010238A2 (en) 2002-04-30
DK1468689T3 (da) 2007-08-13
DE69917663D1 (de) 2004-07-01
HRP20010238B1 (en) 2006-05-31
HK1041199A1 (en) 2002-07-05
PL346981A1 (en) 2002-03-11

Similar Documents

Publication Publication Date Title
UA66872C2 (uk) Сполука, яка є памоатом оланзапіну або його сольватом, та спосіб лікування психотичних розладів
BR9813228A (pt) Formulação de 2-metil-tieno-benzodiazepina
HUP9900457A3 (en) Method, compositions and kits for increasing the oral bioavailability of pharmaceutical agents
IL125735A (en) Pharmaceutical compositions for the treatment of glaucoma comprising an inhibitor of serine-threonine kinase, tyrosine kinase or protein tyrosine phosphatase or an actin-disrupting compound
AU6257798A (en) Treatment of arrhythmias via inhibition of a multifunctional calcium/calmodulin-dependent protein kinase
ZA969001B (en) Method compositions and kits for increasing the oral bioavailability of pharmaceutical agents
AU3153097A (en) Pharmaceutical for treatment of neurological and neuropsychiatric disorders
IL138476A0 (en) Method for treating pharmaceutical compositions by special use of anti-oxidant
IL161833A0 (en) Pharmaceutical compositions and usethereof for thetreatment of psychotic diseases
AU5309400A (en) Methods and compositions for the treatment of neuroleptic and related disorders using sertindole derivatives
BR9713215A (pt) Formulação de partìcula revestida
GB2311940B (en) Pharmaceutical compositions for the treatment of rhinitis
EP1109548A4 (en) COMPOSITIONS AND METHODS FOR TREATING AND PREVENTING BONE DISEASES USING TOCOTRIENOLE
MX9708394A (es) Composicion farmaceutica que contiene clorhidrato de tiagabina y el proceso para su preparacion.
HUP9904030A3 (en) Use of tiagabine for production of pharmaceutical against psychotic disorders
EP0743068A3 (en) Composition for inhibiting bone loss containing vanadyl sulfate
AU6955998A (en) Method for providing neuro-protective effects
AP9600780A0 (en) Process for the preparation of peroxetine hydrochloride anhydrate and its use as therapeutic agent.
MY118194A (en) Pharmaceutical compositions for use in inhibiting bone resorption
JO1909B1 (en) Composition of 2-methylthenio-benzodiazepine oral